Search research articles
Contact Us
Filters
Showing results (101-110 of 186) with videos related to
Page
of 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2018
Biomarkers and Bone Imaging Dynamics Associated with Clinical Outcomes of Oral Cabozantinib Therapy in Metastatic Castrate-Resistant Prostate Cancer
Ulka N Vaishampayan, Izabela Podgorski, Lance K Heilbrun, et al.
Journal of the National Cancer Institute
|
August 24, 2024
Inflammation, physical activity, and disease-free survival in stage III colon cancer: Cancer and Leukemia Group B-Southwest Oncology Group 80702 (Alliance)
Justin C Brown, Chao Ma, Qian Shi, et al.
Journal of Gastrointestinal Oncology
|
August 9, 2019
Molecular profiling of biliary cancers reveals distinct molecular alterations and potential therapeutic targets
Benjamin A Weinberg, Joanne Xiu, Michael R Lindberg, et al.
American Journal of Clinical Oncology
|
December 10, 2003
Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study
Sana Al-Sukhun, Mark M Zalupski, Edgar Ben-Josef, et al.
NPJ Precision Oncology
|
January 20, 2026
Evaluation of immuno-oncologic biomarkers and β-catenin expression in response of hepatocellular carcinomas to immunotherapy
Gaurav Sharma, Yasmine Baca, Sanjay Goel, et al.
Investigational New Drugs
|
January 29, 2010
A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer
Bassel Fuad El-Rayes, Philip A Philip, Fazlul H Sarkar, et al.
British Journal of Sports Medicine
|
March 6, 2023
Association between physical activity and the time course of cancer recurrence in stage III colon cancer
Justin C Brown, Chao Ma, Qian Shi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 11, 2022
Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG 80702
Seohyuk Lee, Chao Ma, Qian Shi, et al.
BMJ Oncology
|
April 8, 2026
CXCR4 mRNA overexpression: an indicator of poor survival and predictor of response to immune checkpoint inhibitors in patients with metastatic colorectal cancer
Sepideh Gholami, Anwaar Saeed, Yasmine Baca, et al.
The Oncologist
|
July 19, 2018
Impact of Patient Age on Molecular Alterations of Left-Sided Colorectal Tumors
Alberto Puccini, Heinz-Josef Lenz, John L Marshall, et al.
Page
of 19
Search research articles
Search
Showing results (101-110 of 186) with videos related to
Sort By:
Page
of 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2018
Biomarkers and Bone Imaging Dynamics Associated with Clinical Outcomes of Oral Cabozantinib Therapy in Metastatic Castrate-Resistant Prostate Cancer
Ulka N Vaishampayan, Izabela Podgorski, Lance K Heilbrun, et al.
Journal of the National Cancer Institute
|
August 24, 2024
Inflammation, physical activity, and disease-free survival in stage III colon cancer: Cancer and Leukemia Group B-Southwest Oncology Group 80702 (Alliance)
Justin C Brown, Chao Ma, Qian Shi, et al.
Journal of Gastrointestinal Oncology
|
August 9, 2019
Molecular profiling of biliary cancers reveals distinct molecular alterations and potential therapeutic targets
Benjamin A Weinberg, Joanne Xiu, Michael R Lindberg, et al.
American Journal of Clinical Oncology
|
December 10, 2003
Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study
Sana Al-Sukhun, Mark M Zalupski, Edgar Ben-Josef, et al.
NPJ Precision Oncology
|
January 20, 2026
Evaluation of immuno-oncologic biomarkers and β-catenin expression in response of hepatocellular carcinomas to immunotherapy
Gaurav Sharma, Yasmine Baca, Sanjay Goel, et al.
Investigational New Drugs
|
January 29, 2010
A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer
Bassel Fuad El-Rayes, Philip A Philip, Fazlul H Sarkar, et al.
British Journal of Sports Medicine
|
March 6, 2023
Association between physical activity and the time course of cancer recurrence in stage III colon cancer
Justin C Brown, Chao Ma, Qian Shi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 11, 2022
Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG 80702
Seohyuk Lee, Chao Ma, Qian Shi, et al.
BMJ Oncology
|
April 8, 2026
CXCR4 mRNA overexpression: an indicator of poor survival and predictor of response to immune checkpoint inhibitors in patients with metastatic colorectal cancer
Sepideh Gholami, Anwaar Saeed, Yasmine Baca, et al.
The Oncologist
|
July 19, 2018
Impact of Patient Age on Molecular Alterations of Left-Sided Colorectal Tumors
Alberto Puccini, Heinz-Josef Lenz, John L Marshall, et al.
Page
of 19